These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers. Tangø M, Carlsen JE, Trap-Jensen J. Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963 [Abstract] [Full Text] [Related]
15. A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure. Jamieson MJ, Webster J, Fowler G, Rawles J, Smith FW, Petrie JC. Br J Clin Pharmacol; 1991 Mar; 31(3):305-12. PubMed ID: 1675867 [Abstract] [Full Text] [Related]
16. Cardioselectivity, kinetics, hemodynamics, and metabolic effects of xamoterol. Jennings G, Bobik A, Oddie C, Restall R. Clin Pharmacol Ther; 1984 May; 35(5):594-603. PubMed ID: 6143634 [Abstract] [Full Text] [Related]
19. Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function. Rousseau MF, Pouleur H, Debaisieux JC, Van Eyll C, Charlier AA. Br J Clin Pharmacol; 1989 May; 28 Suppl 1(Suppl 1):84S-85S. PubMed ID: 2572264 [Abstract] [Full Text] [Related]
20. Acute haemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol at rest and during supine exercise in patients with left ventricular dysfunction due to ischaemic heart disease: a double-blind randomized trial. de Feyter PJ, Serruys PW. Eur Heart J; 1990 Apr; 11 Suppl A():48-9. PubMed ID: 1971590 [Abstract] [Full Text] [Related] Page: [Next] [New Search]